药物经济学和结果研究在中国还是一门新兴的学科。与国际先进水平相比,无论是在理论水平或是研究方法,以及研究的实践来看还有很大的差距,特别是专业人才的匮乏。我们需要加速人才队伍的建设。 Pharmacoeconomics and outcome studies are still a new discipline in China. Compared with the international advanced level, there is still a long way to go in terms of theoretical level and research methods, as well as the practice of the research. In particular, there is a lack of professionals. We need to speed up the building of a talent pool.